NBIX

NEUROCRINE BIOSCIENCES INC

Healthcare | Large Cap

$1.27

EPS Forecast

$747.6

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$1.27

Revenue Forecast:

$747.6

EPS Surprise Forecast:

$0.010

Revenue Surprise Forecast:

$15

Post-release price volatility - Medium

Post-release Overnight Move:

±6.2%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

56%

Probability of beating revenue consensus:

83%

Probability of beating both EPS & revs consensus:

51%

Probability of missing both EPS & revs consensus:

12%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

0.52

Earnings volatility

EPS standard deviation:

$0.33

Revenue standard deviation:

$31

As % of share price:

0.26% HIGH

As % of market cap:

0.24% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$1.73

Revenue 95th %ile:

$791

EPS 75th %ile:

$1.39

Revenue 75th %ile:

$759

EPS 25th %ile:

$1.18

Revenue 25th %ile:

$738

EPS 5th %ile:

$0.93

Revenue 5th %ile:

$712

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

45% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

48% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$11

Bid-ask per Share:

$0.14